Company intelligence / Profile preview

Verdi Oncology

Brentwood, Tennessee, United States

Ownership: Private
Employees: ~90
Development stage: Other

Overview

Verdi Oncology operates a network of community oncology practices and research centers, providing outpatient cancer care and access to clinical trials in a value‑based care model; it is not a drug development company and does not have its own therapeutic pipeline.

Therapeutic areas: Oncology
Industry: Non-Academic Healthcare

Partnerships

Pharos Capital Group (sponsor/major investor and strategic partner)[1][3][4][9]The US Oncology Network (certain Verdi network practices, including Nashville Oncology Associates and Horizon Oncology, joined The US Oncology Network)[3]Integra Connect (value‑based care/OMH+ program at Horizon Oncology, a Verdi network practice)[5]

Beyond the preview

Go deeper on Verdi Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Verdi Oncology.

Explore the full profile